Linked Life Data

17541528

Source:http://linkedlifedata.com/resource/pubmed/id/17541528

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2007-12-28
pubmed:abstractText
Patients with type 2 diabetes are at high risk for the development of micro- and macrovascular complications. It is necessary to aim at an early, multifactorial intervention at different levels of metabolic syndrome. Epidemiological data have consistently shown that postprandial hyperglycaemia has strong proatherogenic effects, increasing overall cardiovascular risk. These findings indicate that intensive blood glucose control with the aim of maintaining near normal preprandial (<110 mg/dl) and postprandial levels (<140 mg/dl) is required to minimise the incidence of complications. Antidiabetic therapy should be selected individually by integrating therapeutic goals and the patient's possibilities for self-management. The fact that national recommendations for the treatment of patients with type 2 diabetes are not fully implemented in clinical practice emphasizes the importance of further activities to improve the quality of care.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0020-9554
pubmed:author
pubmed:issnType
Print
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
676, 678-80, 682 passim
pubmed:dateRevised
2009-11-3
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
[Blood glucose control in type 2 diabetes. Basic requirements for reducing vascular complications].
pubmed:affiliation
Diabeteszentrum, Medizinische Klinik- Innenstadt, Klinikum der Ludwig-Maximilians-Universität München. Jochen.Seissler@med.uni-muenchen.de
pubmed:publicationType
Journal Article, English Abstract, Review